S-1 · primary offering
Issued 2023
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Services-Commercial Physical & Biological ResearchIndustry: Shell CompaniesCountry: USExchange: Nasdaq
DilutionScan read 16 of IB Acquisition Corp.'s SEC filings and found 1 warrant series, 5 convertibles, 1 equity line, 1 S-1 registration and 1 completed offering on file for IBAC. Analysis updated Oct 13, 2026.
Raise routes on file: no active ATM, effective shelf, S-1 or equity line in the filings read · latest dilution event 49 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Sep 15, 2026 · Offering Priced
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2023
Proposed maximum
Shares registered
Issued 2026
Shares Underlying
Exercise Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Issued 2026
Commitment
Sold to date
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Shell Companies. All tickers A to Z